
Rocket Companies (RKT) and Xenon Pharmaceuticals (XENE) are experiencing elevated options trading volumes, with RKT's 106,242 contracts representing 43.4% of its average daily volume and XENE's 4,032 contracts accounting for 42.1%. This activity is concentrated in specific long-dated contracts: a high volume of $18.50 strike call options for RKT expiring August 15, 2025, and $35 strike put options for XENE expiring October 17, 2025, signaling notable directional bets or hedging strategies by market participants.
Rocket Companies (RKT) and Xenon Pharmaceuticals (XENE) are exhibiting notable options market activity, indicating focused investor positioning. For RKT, the options volume of 106,242 contracts represents a significant 43.4% of its average daily share volume, highlighting unusual interest. This activity is heavily concentrated in the August 15, 2025, $18.50 strike call options, suggesting a specific, long-term bullish bet on the stock's appreciation above this level. Similarly, XENE's options volume equates to 42.1% of its average daily share turnover, with a pronounced concentration of 3,501 contracts on the October 17, 2025, $35 strike put option. This specific put activity points towards a significant bearish stance or a substantial hedging strategy against a potential price decline below $35 over the long term. The long-dated nature of these concentrated trades in both securities implies that market participants are positioning for medium-to-long-term outcomes rather than short-term volatility or a near-term catalyst.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment